PPARGC1A and hepatocellular carcinoma: Moreover, mitochondrial transcription factor B2 (TFB2M), acts as a pivotal oncogene in HCC (57), decreases PGC1α expression at both mRNA and protein level through SIRT3/HIF-1α signaling (58).